Tamoxigenat, created in 1986 (Germany), from 2951 sister brands and 17477 competing brands. Tamoxigenat is owned by NOVARTIS N, listed on the stock exchange of Zurich The ISIN, the company's International Securities Identification Number, is CH0012005267. Tamoxigenat belongs to the Drug Manufacturers business sector.

Tamoxigenat is a brand of NOVARTIS N (NOVN) Share price

Share price and profitability of the share NOVARTIS N (Tamoxigenat)

Buy NOVARTIS N share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested CHF 89.05

Portfolio valuation
NOVARTIS N (Tamoxigenat) over 5 years* CHF 100.35

Stock market history NOVARTIS N (Tamoxigenat)

Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more